0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global New Drug Modeling Solution Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3J15312
Home | Market Reports | Computers & Electronics| Software
Global New Drug Modeling Solution Market Research Report 2023
BUY CHAPTERS

Global New Drug Modeling Solution Market Research Report 2025

Code: QYRE-Auto-3J15312
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

New Drug Modeling Solution Market

The global market for New Drug Modeling Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for New Drug Modeling Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for New Drug Modeling Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for New Drug Modeling Solution in Drug Discovery and Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of New Drug Modeling Solution include JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes, Acellera, lnstem(Leadscope), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for New Drug Modeling Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Drug Modeling Solution.
The New Drug Modeling Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Drug Modeling Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Drug Modeling Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of New Drug Modeling Solution Market Report

Report Metric Details
Report Name New Drug Modeling Solution Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes, Acellera, lnstem(Leadscope)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of New Drug Modeling Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the New Drug Modeling Solution Market report?

Ans: The main players in the New Drug Modeling Solution Market are JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes, Acellera, lnstem(Leadscope)

What are the Application segmentation covered in the New Drug Modeling Solution Market report?

Ans: The Applications covered in the New Drug Modeling Solution Market report are Drug Discovery and Development, Computational Physiological Medicine, Disease Modeling, Others

What are the Type segmentation covered in the New Drug Modeling Solution Market report?

Ans: The Types covered in the New Drug Modeling Solution Market report are Database, Software, Others

Recommended Reports

Drug Discovery Services

Cancer Treatment Solutions

Pharma Digital Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Drug Modeling Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Database
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global New Drug Modeling Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Drug Modeling Solution Market Perspective (2020-2031)
2.2 Global New Drug Modeling Solution Growth Trends by Region
2.2.1 Global New Drug Modeling Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 New Drug Modeling Solution Historic Market Size by Region (2020-2025)
2.2.3 New Drug Modeling Solution Forecasted Market Size by Region (2026-2031)
2.3 New Drug Modeling Solution Market Dynamics
2.3.1 New Drug Modeling Solution Industry Trends
2.3.2 New Drug Modeling Solution Market Drivers
2.3.3 New Drug Modeling Solution Market Challenges
2.3.4 New Drug Modeling Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Drug Modeling Solution Players by Revenue
3.1.1 Global Top New Drug Modeling Solution Players by Revenue (2020-2025)
3.1.2 Global New Drug Modeling Solution Revenue Market Share by Players (2020-2025)
3.2 Global New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by New Drug Modeling Solution Revenue
3.4 Global New Drug Modeling Solution Market Concentration Ratio
3.4.1 Global New Drug Modeling Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Drug Modeling Solution Revenue in 2024
3.5 Global Key Players of New Drug Modeling Solution Head office and Area Served
3.6 Global Key Players of New Drug Modeling Solution, Product and Application
3.7 Global Key Players of New Drug Modeling Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Drug Modeling Solution Breakdown Data by Type
4.1 Global New Drug Modeling Solution Historic Market Size by Type (2020-2025)
4.2 Global New Drug Modeling Solution Forecasted Market Size by Type (2026-2031)
5 New Drug Modeling Solution Breakdown Data by Application
5.1 Global New Drug Modeling Solution Historic Market Size by Application (2020-2025)
5.2 Global New Drug Modeling Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America New Drug Modeling Solution Market Size (2020-2031)
6.2 North America New Drug Modeling Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America New Drug Modeling Solution Market Size by Country (2020-2025)
6.4 North America New Drug Modeling Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Drug Modeling Solution Market Size (2020-2031)
7.2 Europe New Drug Modeling Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe New Drug Modeling Solution Market Size by Country (2020-2025)
7.4 Europe New Drug Modeling Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Drug Modeling Solution Market Size (2020-2031)
8.2 Asia-Pacific New Drug Modeling Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific New Drug Modeling Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific New Drug Modeling Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Drug Modeling Solution Market Size (2020-2031)
9.2 Latin America New Drug Modeling Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America New Drug Modeling Solution Market Size by Country (2020-2025)
9.4 Latin America New Drug Modeling Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Drug Modeling Solution Market Size (2020-2031)
10.2 Middle East & Africa New Drug Modeling Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa New Drug Modeling Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa New Drug Modeling Solution Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 JSR Corporation(Crown Bioscience)
11.1.1 JSR Corporation(Crown Bioscience) Company Details
11.1.2 JSR Corporation(Crown Bioscience) Business Overview
11.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Introduction
11.1.4 JSR Corporation(Crown Bioscience) Revenue in New Drug Modeling Solution Business (2020-2025)
11.1.5 JSR Corporation(Crown Bioscience) Recent Development
11.2 Chemical Computing Group ULC
11.2.1 Chemical Computing Group ULC Company Details
11.2.2 Chemical Computing Group ULC Business Overview
11.2.3 Chemical Computing Group ULC New Drug Modeling Solution Introduction
11.2.4 Chemical Computing Group ULC Revenue in New Drug Modeling Solution Business (2020-2025)
11.2.5 Chemical Computing Group ULC Recent Development
11.3 Nimbus Therapeutics
11.3.1 Nimbus Therapeutics Company Details
11.3.2 Nimbus Therapeutics Business Overview
11.3.3 Nimbus Therapeutics New Drug Modeling Solution Introduction
11.3.4 Nimbus Therapeutics Revenue in New Drug Modeling Solution Business (2020-2025)
11.3.5 Nimbus Therapeutics Recent Development
11.4 schrodinger, Inc
11.4.1 schrodinger, Inc Company Details
11.4.2 schrodinger, Inc Business Overview
11.4.3 schrodinger, Inc New Drug Modeling Solution Introduction
11.4.4 schrodinger, Inc Revenue in New Drug Modeling Solution Business (2020-2025)
11.4.5 schrodinger, Inc Recent Development
11.5 Genedata AG
11.5.1 Genedata AG Company Details
11.5.2 Genedata AG Business Overview
11.5.3 Genedata AG New Drug Modeling Solution Introduction
11.5.4 Genedata AG Revenue in New Drug Modeling Solution Business (2020-2025)
11.5.5 Genedata AG Recent Development
11.6 Biognos AB
11.6.1 Biognos AB Company Details
11.6.2 Biognos AB Business Overview
11.6.3 Biognos AB New Drug Modeling Solution Introduction
11.6.4 Biognos AB Revenue in New Drug Modeling Solution Business (2020-2025)
11.6.5 Biognos AB Recent Development
11.7 Compugen Ltd
11.7.1 Compugen Ltd Company Details
11.7.2 Compugen Ltd Business Overview
11.7.3 Compugen Ltd New Drug Modeling Solution Introduction
11.7.4 Compugen Ltd Revenue in New Drug Modeling Solution Business (2020-2025)
11.7.5 Compugen Ltd Recent Development
11.8 Dassault Systemes
11.8.1 Dassault Systemes Company Details
11.8.2 Dassault Systemes Business Overview
11.8.3 Dassault Systemes New Drug Modeling Solution Introduction
11.8.4 Dassault Systemes Revenue in New Drug Modeling Solution Business (2020-2025)
11.8.5 Dassault Systemes Recent Development
11.9 Acellera
11.9.1 Acellera Company Details
11.9.2 Acellera Business Overview
11.9.3 Acellera New Drug Modeling Solution Introduction
11.9.4 Acellera Revenue in New Drug Modeling Solution Business (2020-2025)
11.9.5 Acellera Recent Development
11.10 lnstem(Leadscope)
11.10.1 lnstem(Leadscope) Company Details
11.10.2 lnstem(Leadscope) Business Overview
11.10.3 lnstem(Leadscope) New Drug Modeling Solution Introduction
11.10.4 lnstem(Leadscope) Revenue in New Drug Modeling Solution Business (2020-2025)
11.10.5 lnstem(Leadscope) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global New Drug Modeling Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Database
 Table 3. Key Players of Software
 Table 4. Key Players of Others
 Table 5. Global New Drug Modeling Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global New Drug Modeling Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global New Drug Modeling Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global New Drug Modeling Solution Market Share by Region (2020-2025)
 Table 9. Global New Drug Modeling Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global New Drug Modeling Solution Market Share by Region (2026-2031)
 Table 11. New Drug Modeling Solution Market Trends
 Table 12. New Drug Modeling Solution Market Drivers
 Table 13. New Drug Modeling Solution Market Challenges
 Table 14. New Drug Modeling Solution Market Restraints
 Table 15. Global New Drug Modeling Solution Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global New Drug Modeling Solution Market Share by Players (2020-2025)
 Table 17. Global Top New Drug Modeling Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug Modeling Solution as of 2024)
 Table 18. Ranking of Global Top New Drug Modeling Solution Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by New Drug Modeling Solution Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of New Drug Modeling Solution, Headquarters and Area Served
 Table 21. Global Key Players of New Drug Modeling Solution, Product and Application
 Table 22. Global Key Players of New Drug Modeling Solution, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global New Drug Modeling Solution Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global New Drug Modeling Solution Revenue Market Share by Type (2020-2025)
 Table 26. Global New Drug Modeling Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global New Drug Modeling Solution Revenue Market Share by Type (2026-2031)
 Table 28. Global New Drug Modeling Solution Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global New Drug Modeling Solution Revenue Market Share by Application (2020-2025)
 Table 30. Global New Drug Modeling Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global New Drug Modeling Solution Revenue Market Share by Application (2026-2031)
 Table 32. North America New Drug Modeling Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America New Drug Modeling Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America New Drug Modeling Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe New Drug Modeling Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe New Drug Modeling Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe New Drug Modeling Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific New Drug Modeling Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific New Drug Modeling Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific New Drug Modeling Solution Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America New Drug Modeling Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America New Drug Modeling Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America New Drug Modeling Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa New Drug Modeling Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa New Drug Modeling Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa New Drug Modeling Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 47. JSR Corporation(Crown Bioscience) Company Details
 Table 48. JSR Corporation(Crown Bioscience) Business Overview
 Table 49. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product
 Table 50. JSR Corporation(Crown Bioscience) Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 51. JSR Corporation(Crown Bioscience) Recent Development
 Table 52. Chemical Computing Group ULC Company Details
 Table 53. Chemical Computing Group ULC Business Overview
 Table 54. Chemical Computing Group ULC New Drug Modeling Solution Product
 Table 55. Chemical Computing Group ULC Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 56. Chemical Computing Group ULC Recent Development
 Table 57. Nimbus Therapeutics Company Details
 Table 58. Nimbus Therapeutics Business Overview
 Table 59. Nimbus Therapeutics New Drug Modeling Solution Product
 Table 60. Nimbus Therapeutics Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 61. Nimbus Therapeutics Recent Development
 Table 62. schrodinger, Inc Company Details
 Table 63. schrodinger, Inc Business Overview
 Table 64. schrodinger, Inc New Drug Modeling Solution Product
 Table 65. schrodinger, Inc Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 66. schrodinger, Inc Recent Development
 Table 67. Genedata AG Company Details
 Table 68. Genedata AG Business Overview
 Table 69. Genedata AG New Drug Modeling Solution Product
 Table 70. Genedata AG Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 71. Genedata AG Recent Development
 Table 72. Biognos AB Company Details
 Table 73. Biognos AB Business Overview
 Table 74. Biognos AB New Drug Modeling Solution Product
 Table 75. Biognos AB Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 76. Biognos AB Recent Development
 Table 77. Compugen Ltd Company Details
 Table 78. Compugen Ltd Business Overview
 Table 79. Compugen Ltd New Drug Modeling Solution Product
 Table 80. Compugen Ltd Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 81. Compugen Ltd Recent Development
 Table 82. Dassault Systemes Company Details
 Table 83. Dassault Systemes Business Overview
 Table 84. Dassault Systemes New Drug Modeling Solution Product
 Table 85. Dassault Systemes Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 86. Dassault Systemes Recent Development
 Table 87. Acellera Company Details
 Table 88. Acellera Business Overview
 Table 89. Acellera New Drug Modeling Solution Product
 Table 90. Acellera Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 91. Acellera Recent Development
 Table 92. lnstem(Leadscope) Company Details
 Table 93. lnstem(Leadscope) Business Overview
 Table 94. lnstem(Leadscope) New Drug Modeling Solution Product
 Table 95. lnstem(Leadscope) Revenue in New Drug Modeling Solution Business (2020-2025) & (US$ Million)
 Table 96. lnstem(Leadscope) Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. New Drug Modeling Solution Picture
 Figure 2. Global New Drug Modeling Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global New Drug Modeling Solution Market Share by Type: 2024 VS 2031
 Figure 4. Database Features
 Figure 5. Software Features
 Figure 6. Others Features
 Figure 7. Global New Drug Modeling Solution Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global New Drug Modeling Solution Market Share by Application: 2024 VS 2031
 Figure 9. Drug Discovery and Development Case Studies
 Figure 10. Computational Physiological Medicine Case Studies
 Figure 11. Disease Modeling Case Studies
 Figure 12. Others Case Studies
 Figure 13. New Drug Modeling Solution Report Years Considered
 Figure 14. Global New Drug Modeling Solution Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global New Drug Modeling Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global New Drug Modeling Solution Market Share by Region: 2024 VS 2031
 Figure 17. Global New Drug Modeling Solution Market Share by Players in 2024
 Figure 18. Global Top New Drug Modeling Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug Modeling Solution as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by New Drug Modeling Solution Revenue in 2024
 Figure 20. North America New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America New Drug Modeling Solution Market Share by Country (2020-2031)
 Figure 22. United States New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe New Drug Modeling Solution Market Share by Country (2020-2031)
 Figure 26. Germany New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific New Drug Modeling Solution Market Share by Region (2020-2031)
 Figure 34. China New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America New Drug Modeling Solution Market Share by Country (2020-2031)
 Figure 42. Mexico New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa New Drug Modeling Solution Market Share by Country (2020-2031)
 Figure 46. Turkey New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE New Drug Modeling Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. JSR Corporation(Crown Bioscience) Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 50. Chemical Computing Group ULC Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 51. Nimbus Therapeutics Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 52. schrodinger, Inc Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 53. Genedata AG Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 54. Biognos AB Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 55. Compugen Ltd Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 56. Dassault Systemes Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 57. Acellera Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 58. lnstem(Leadscope) Revenue Growth Rate in New Drug Modeling Solution Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Data Visualization Analysis Tools Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19901
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Digital Mortgage Loan Solutions Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34K19435
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global IT Asset Inventory Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8U19855
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Computer-Aided Dispatch (CAD) Software for Public Safety Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7D19969
Mon Sep 08 00:00:00 UTC 2025

Add to Cart